Derek Nuamah

Derek Nuamah

Auto-generated profile, based on publicly available information

Derek Nuamah

University of Miami Miller School of Medicine, Miami, FL

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2026 in Urology
Verified
Journal Article
Closed access
DNDerek Nuamah
Derek Nuamah
NSNikita Sharma
Nikita Sharma
CEChristabel Egemba
Christabel Egemba
CCChelsea Caplan
Chelsea Caplan
KAKatherine Amin
Katherine Amin
RSRaveen Syan
Raveen Syan

21 August 2025 in Therapeutics
Verified
Journal Article
Open access
PDF file
CAChrishaun Alexander
Chrishaun Alexander
AHAkeem Henry
Akeem Henry
DNDerek Nuamah
Derek Nuamah
JLJoshua Ellis Lewis
Joshua Ellis Lewis
BGBryce Gantt
Bryce Gantt
OIOyetokunbo Ibidapo-Obe
Oyetokunbo Ibidapo-Obe
Background/Objectives: Gender-affirming surgery (GAS) is associated with improved mental health outcomes in transgender and gender-diverse (TGD) individuals. However, TGD populations experience disproportionately high rates of substance use disorders (SUDs), which are established risk factors for surgical complications. Despite this, the relationship between preoperative SUDs and postoperative outcomes following GAS has not been studied. Our objective was to evaluate how specific SUD subtypes, including tobacco, alcohol, and cannabis, impact short- and medium-term postoperative complications following GAS. Methods: A retrospective cohort study was conducted using the TriNetX Research Network, which includes de-identified electronic health records from over 100 million U.S. patients. Adults with documented gender dysphoria who underwent GAS between April 2015 and April 2025 were included. Patients were divided into four groups: no SUD, tobacco use, alcohol use, and cannabis use. Propensity score matching was used to control for demographic variables. Postoperative complications were assessed at 30 days and 6 months. Results: Alcohol use was significantly associated with increased rates of delayed wound healing, wound dehiscence, gastrointestinal symptoms, and postoperative pain at both 30 days and 6 months. Cannabis use was linked to higher rates of wound dehiscence, infections, GI symptoms, and pain. Tobacco use showed the broadest impact, significantly associated with nearly all complications measured except pain at 30 days. These associations persisted at six months. Conclusions: This is the first study to quantify the relationship between substance use and GAS outcomes. Preoperative use of tobacco, alcohol, and cannabis was independently associated with increased postoperative complications. These findings underscore the need for systematic preoperative screening and the development of SUD-specific perioperative care pathways to improve outcomes and advance equity in surgical care for TGD patients.